Evaluation of combretastatin A-4 prodrug in a non-Hodgkin's lymphoma xenograft model: Preclinical efficacy

Anti-Cancer Drugs

Volumn 12, Issue 1, 2001, Pages 57-63

  Nabha, S M ^a   Mohammad, R M ^a   Wall, N R ^a   Dutcher, J A ^a   Salkini, B M ^a   Pettit, G R ^a   Al Katib, A M ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiangiogenesis; Antitumor activity; CD31; Combretastatin A 4 prodrug; Non Hodgkin's lymphoma; SCID mice

Indexed keywords

CD31 ANTIGEN; COMBRETASTATIN A4;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD VESSEL; CELL CYCLE G2 PHASE; CELL DEATH; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPHOID CELL; MITOSIS INHIBITION; MOUSE; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; TREATMENT PLANNING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL CYCLE; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MAXIMUM TOLERATED DOSE; MICE; MICE, INBRED ICR; MICE, SCID; NEOVASCULARIZATION, PATHOLOGIC; PRODRUGS; STILBENES; SURVIVAL RATE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035129337     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200101000-00008     Document Type: Article

References (23)

1. Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A4
2. The interaction with tubulin of a series of stilbenes based on combretastatin A-4
3. Antineoplastic agents 393. Synthesis of the trans-isomer of combretastatin A-4 prodrug
4. Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature
5. Antivascular approaches to solid tumor therapy: Evaluation of combretastatin A4 phosphate
6. What is the evidence that tumors are angiogenesis dependent?
7. Angiostatin induces and sustains dormancy of human primary tumors in mice
8. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
9. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
10. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
11. The micro-tubule-affecting drug paclitaxel has antiangiogenic activity
12. Thalidomide is an inhibitor of angiogenesis
13. Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol
14. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer
15. Antiangiogenesis is produced by nontoxic doses of vinblastine
16. Cancer statistics 2000
17. Effects of Combretastatin A-4 prodrug against a panel of malignant human B-lymphoid cell lines
18. Bryostatin-1 down-regulates mdr1 and potentiates vincristine cytotoxicity in diffuse large cell lymphoma xenografts
19. Angiogenesis in cancer, vascular, rheumatoid and other disease
20. Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma
21. The new tublin-inhibitor combretastatin A-4 enhances thermal damage in the BT4An rat glioma
22. Combretastatin A-4 phosphate as a tumor vascular-targeting agent: Early effects in tumors and normal tissues
23. Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry